The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q2 2022 call → NOWe need to determine if management conveys that the reported results do not represent the business as it is actually running today — that the reported period is stale relative to the operating present. Look for repeated or substantial indications that the just-reported numbers describe a company already left behind by what is now happening. Scan the transcript for such language. Management discusses strong results, guidance reaffirmed, but also mentions ongoing initiatives, acquisitions, recruiting, etc. However, the question is about a specific posture: the reported period is stale relative to the operating present. Do they say that the current business is ahead of the reported period? For example, they mention that they have deployed capital, acquired facilities, recruited physicians, but these are part of the period or just after. They also mention that they are managing inflation, but that's not a gap. Look for phrases like "the business as it stands today is ahead of the business as it appears in the reported period." They do say things like "we ended the quarter with strong momentum" and "we are optimistic" but that's typical. They also mention that they have a robust pipeline, but that's future. One key point: They mention that they acquired minority stakes and de novos, and that these will help future growth. But they don't say that the reported numbers are stale. They reaffirm guidance. They talk about managing inflation, but that's not a gap. The question asks: Does management convey that the reported results do not represent the business they are actually running today? That would be if they say something like "the results are behind where we are now" or "we have already moved beyond these numbers." I don't see that. They are positive about the quarter and reaffirm guidance. They talk about momentum, but that's normal. They also mention that they have deployed $135 million on acquisitions year-to-date, but that's part of the period or just after. They don't say that the reported period didn't include the benefits of these acquisitions. They do say that some acquisitions are non-consolidating, so they don't show revenue, but they still contribute EBITDA.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.